{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T16:22:29Z","timestamp":1715098949982},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"DOI":"10.7759\/cureus.21124","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T18:19:48Z","timestamp":1641925188000},"source":"Crossref","is-referenced-by-count":1,"title":["Clindamycin Efficacy in Patients With Methicillin-Sensitive Staphylococcus aureus in a Fourth-Level Hospital in the City of Medell\u00edn"],"prefix":"10.7759","author":[{"given":"Jose C","family":"Alvarez-Payares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair E.","family":"Palacios M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"De la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huxdley B.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Giraldo-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Rodelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"\u00c1gamez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/598189","article-title":"Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies","volume":"48","author":"Naber CK","year":"2009","unstructured":"Naber CK. Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009, 48:S231-7. 10.1086\/598189","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland TL","year":"2014","unstructured":"Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014, 312:1330-41. 10.1001\/jama.2014.9743","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000073163.37519.ee","article-title":"Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children","volume":"22","author":"Mart\u00ednez-Aguilar G","year":"2003","unstructured":"Mart\u00ednez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003, 22:593-8. 10.1097\/01.inf.0000073163.37519.ee","journal-title":"Pediatr Infect Dis J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab036","article-title":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK","volume":"76","author":"Brown NM","year":"2021","unstructured":"Brown NM, Brown EM. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. J Antimicrob Chemother. 2021, 76:1377-8. 10.1093\/jac\/dkab036","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.05.003","article-title":"Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases","volume":"38","author":"Gillet Y","year":"2011","unstructured":"Gillet Y, Dumitrescu O, Tristan A, et al.. Pragmatic management of Panton-Valentine leukocidin-associated staphylococcal diseases. Int J Antimicrob Agents. 2011, 38:457-64. 10.1016\/j.ijantimicag.2011.05.003","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky387","article-title":"Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal","volume":"74","author":"Campbell AJ","year":"2019","unstructured":"Campbell AJ, Dotel R, Blyth CC, Davis JS, Tong SY, Bowen AC. Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal. J Antimicrob Chemother. 2019, 74:1-5. 10.1093\/jac\/dky387","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.13140\/2.1.3365.4088","article-title":"In vivo efficacy of four generic products of clindamycin compared with the original compound in the neutropenic mouse thigh infection model","author":"Zuluaga AF","year":"2007","unstructured":"Zuluaga AF, Agudelo M, Rodriguez CA, Vesga O. In vivo efficacy of four generic products of clindamycin compared with the original compound in the neutropenic mouse thigh infection model. Int J Antimicrob Ag. 2007, 1-2. 10.13140\/2.1.3365.4088","journal-title":"Int J Antimicrob Ag"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30447-3","article-title":"Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study","volume":"20","author":"Kuehl R","year":"2020","unstructured":"Kuehl R, Morata L, Boeing C, et al.. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study. Lancet Infect Dis. 2020, 20:1409-17. 10.1016\/S1473-3099(20)30447-3","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy739","article-title":"A prognostic model of persistent bacteremia and mortality in complicated Staphylococcus aureus bloodstream infection","volume":"68","author":"Guimaraes AO","year":"2019","unstructured":"Guimaraes AO, Cao Y, Hong K, et al.. A prognostic model of persistent bacteremia and mortality in complicated Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2019, 68:1502-11. 10.1093\/cid\/ciy739","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira FL","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, M\u00e9lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001, 286:1754-8. 10.1001\/jama.286.14.1754","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0903.2001.00029.x","article-title":"Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality","volume":"31","author":"Hill PC","year":"2001","unstructured":"Hill PC, Birch M, Chambers S, et al.. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001, 31:97-103. 10.1111\/j.1444-0903.2001.00029.x","journal-title":"Intern Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa341","article-title":"Outcomes of outpatient parenteral antimicrobial therapy with ceftriaxone for methicillin-susceptible Staphylococcus aureus bloodstream Infections-a single-center observational study","volume":"7","author":"Hamad Y","year":"2020","unstructured":"Hamad Y, Connor L, Bailey TC, George IA. Outcomes of outpatient parenteral antimicrobial therapy with ceftriaxone for methicillin-susceptible Staphylococcus aureus bloodstream Infections-a single-center observational study. Open Forum Infect Dis. 2020, 7:ofaa341. 10.1093\/ofid\/ofaa341","journal-title":"Open Forum Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2020.04.006","article-title":"Comparison of nafcillin and cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia","volume":"360","author":"Twilla JD","year":"2020","unstructured":"Twilla JD, Algrim A, Adams EH, Samarin M, Cummings C, Finch CK. Comparison of nafcillin and cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. Am J Med Sci. 2020, 360:35-41. 10.1016\/j.amjms.2020.04.006","journal-title":"Am J Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2020.01.018","article-title":"Therapy of Staphylococcus aureus bacteremia: evidences and challenges","volume":"38","author":"L\u00f3pez-Cort\u00e9s LE","year":"2020","unstructured":"L\u00f3pez-Cort\u00e9s LE, G\u00e1lvez-Acebal J, Rodr\u00edguez-Ba\u00f1o J. Therapy of Staphylococcus aureus bacteremia: evidences and challenges. Enferm Infecc Microbiol Clin (Engl Ed). 2020, 38:489-97. 10.1016\/j.eimc.2020.01.018","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.1.25","article-title":"Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases","volume":"162","author":"Jensen AG","year":"2002","unstructured":"Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinh\u00f8j P, Frimodt-M\u00f8ller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002, 162:25-32. 10.1001\/archinte.162.1.25","journal-title":"Arch Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.07.019","article-title":"Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study","volume":"26","author":"Abbas M","year":"2020","unstructured":"Abbas M, Rossel A, de Kraker ME, et al.. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study. Clin Microbiol Infect. 2020, 26:626-31. 10.1016\/j.cmi.2019.07.019","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus bacteremia","volume":"25","author":"van Hal SJ","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012, 25:362-86. 10.1128\/CMR.05022-11","journal-title":"Clin Microbiol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-2914-y","article-title":"Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study","volume":"36","author":"Sasson G","year":"2017","unstructured":"Sasson G, Bai AD, Showler A, et al.. Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017, 36:1231-41. 10.1007\/s10096-017-2914-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","author":"Kaech C","year":"2006","unstructured":"Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006, 12:345-52. 10.1111\/j.1469-0691.2005.01359.x","journal-title":"Clin Microbiol Infect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088197","article-title":"Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality","volume":"9","author":"Greenberg JA","year":"2014","unstructured":"Greenberg JA, David MZ, Hall JB, Kress JP. Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality. PLoS One. 2014, 9:e88197. 10.1371\/journal.pone.0088197","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81901-clindamycin-efficacy-in-patients-with-methicillin-sensitive-staphylococcus-aureus-in-a-fourth-level-hospital-in-the-city-of-medelln","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:06Z","timestamp":1707507726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81901-clindamycin-efficacy-in-patients-with-methicillin-sensitive-staphylococcus-aureus-in-a-fourth-level-hospital-in-the-city-of-medelln"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.21124","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,11]]}}}